{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:51:04Z","timestamp":1791546664062,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General Organization For Teaching Hospitals and Institutes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative pain following total hip arthroplasty (THA) and total knee arthroplasty (TKA) drives opioid dependence. Perioperative duloxetine is an option as a multimodal analgesic adjunct, yet its efficacy and safety in this population are not fully defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis compared perioperative duloxetine to placebo in THA and TKA patients, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and registered with the International Prospective Register of Systematic Reviews (PROSPERO) (CRD420261294277). The search strategy spanned PubMed, Web of Science, and Scopus. The Cochrane Library was also queried from inception to March 2, 2026. The primary outcomes were Visual Analog Scale (VAS) pain scores at rest and during ambulation; secondary outcomes included postoperative opioid consumption and the incidence of adverse effects. VAS and Numeric Rating Scale (NRS) pain scores were converted to a common 0\u2013100\u00a0mm scale for pooling and expressed as mean differences (MD) with 95% confidence intervals (CI); opioid consumption was standardized to morphine milligram equivalents (MME) and expressed as MD in MME. Dichotomous data were expressed as risk ratios (RR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirteen randomized controlled trials (RCTs) (n = 1176) were included. Duloxetine significantly reduced pain at rest (MD \u2212\u00a05.09\u00a0mm, 95% CI \u2212\u00a08.76 to \u2212\u00a01.43,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.006) and during ambulation (MD \u2212\u00a04.55\u00a0mm, 95% CI \u2212\u00a08.71 to \u22120.40,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.03) at 24\u00a0h. Analgesic benefits persisted at 2\u00a0weeks (rest pain: MD \u2212\u00a06.48\u00a0mm, 95% CI \u2212\u00a011.14 to \u2212\u00a01.82,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.006; ambulatory pain: MD \u2212\u00a08.93\u00a0mm, 95% CI \u2212\u00a013.16 to \u2212\u00a04.69,\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.0001) and \u22653\u00a0months (rest pain: MD \u2212\u00a02.79\u00a0mm, 95% CI \u2212\u00a04.93 to \u2212\u00a00.64,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.01; ambulatory pain: MD \u2212\u00a03.76\u00a0mm, 95% CI \u2212\u00a06.62 to \u2212\u00a00.89,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.01). After standardization to morphine milligram equivalents (MME), statistically significant opioid-sparing effects were observed at 48\u00a0h (MD \u2212\u00a022.74 MME, 95% CI \u2212\u00a044.17 to \u2212\u00a01.31,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.04, I\n                      <jats:sup>2<\/jats:sup>\n                      = 100%) and 72\u00a0h (MD \u2212\u00a010.58 MME, 95% CI \u2212\u00a018.67 to \u2212\u00a02.49,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.01); both estimates were subject to extreme heterogeneity, and the 48-h estimate in particular should be interpreted with substantial caution given its very wide interval. Duloxetine significantly reduced the risk of nausea\/vomiting (RR 0.73, 95% CI 0.55\u20130.97,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.03); a borderline reduction in fatigue was also observed (RR 0.87, 95% CI 0.76\u20130.996,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.04). Duloxetine increased the risk of drowsiness\/somnolence (RR 1.88,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Perioperative duloxetine produces statistically significant, though sub-threshold, analgesic effects across all assessed timepoints and a selective opioid-sparing effect spanning 48 to 72\u00a0h postoperatively when incorporated into multimodal analgesia for THA and TKA. All findings are subject to substantial heterogeneity and should be interpreted with caution. Duloxetine significantly reduced the incidence of nausea\/vomiting and increased the risk of drowsiness\/somnolence, the latter warranting preoperative patient counseling; a borderline reduction in fatigue was also observed. However, on leave-one-out sensitivity analysis, the long-term (\u2265\u20093-month) reduction in pain at rest, the nausea\/vomiting reduction, and the fatigue reduction each lost statistical significance upon exclusion of a single high-risk trial (Inamullah 2023) and should be interpreted with corresponding caution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13018-026-07176-6","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:44:51Z","timestamp":1788331491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Duloxetine for postoperative pain management in total hip and knee arthroplasty: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2549-2519","authenticated-orcid":false,"given":"Abdelrahman","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdelnabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda Ali","family":"Sheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"7176_CR1","doi-asserted-by":"publisher","first-page":"e28320","DOI":"10.2196\/28320","volume":"23","author":"J Colomina","year":"2021","unstructured":"Colomina J, Drudis R, Torra M, Pallis\u00f3 F, Massip M, Vargiu E, et al. Implementing mHealth-enabled integrated care for complex chronic patients with osteoarthritis undergoing primary hip or knee arthroplasty: prospective, two-arm, parallel trial. J Med Internet Res. 2021;23:e28320. https:\/\/doi.org\/10.2196\/28320.","journal-title":"J Med Internet Res"},{"key":"7176_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1186\/s13018-024-05324-4","volume":"19","author":"C Zhao","year":"2024","unstructured":"Zhao C, Liao Q, Yang D, Yang M, Xu P. Advances in perioperative pain management for total knee arthroplasty: a review of multimodal analgesic approaches. J Orthop Surg Res. 2024;19:843. https:\/\/doi.org\/10.1186\/s13018-024-05324-4.","journal-title":"J Orthop Surg Res"},{"key":"7176_CR3","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1007\/s10067-026-08042-w","volume":"45","author":"G Awad","year":"2026","unstructured":"Awad G, Saad J-P, Hamyeh A, Boutros M. Efficacy and safety of intra-articular mesenchymal stem cell\u2013based therapies in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Clin Rheumatol. 2026;45:2905\u201342. https:\/\/doi.org\/10.1007\/s10067-026-08042-w.","journal-title":"Clin Rheumatol"},{"key":"7176_CR4","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.arth.2024.01.063","volume":"39","author":"Z Dawson","year":"2024","unstructured":"Dawson Z, Stanton SS, Roy S, Farjo R, Aslesen HA, Hallstrom BR, et al. Opioid consumption after discharge from total knee and hip arthroplasty: a systematic review and meta-analysis. J Arthroplasty. 2024;39:2130-2136.e7. https:\/\/doi.org\/10.1016\/j.arth.2024.01.063.","journal-title":"J Arthroplasty"},{"key":"7176_CR5","doi-asserted-by":"publisher","DOI":"10.58616\/001c.130902","author":"S Ramtin","year":"2025","unstructured":"Ramtin S. Oral multi-modal agents for post-operative pain management: a current concept. SurgiColl. 2025. https:\/\/doi.org\/10.58616\/001c.130902.","journal-title":"SurgiColl"},{"key":"7176_CR6","doi-asserted-by":"publisher","DOI":"10.52965\/001c.37496","author":"K Berardino","year":"2022","unstructured":"Berardino K, Carroll AH, Ricotti R, Popovsky D, Civilette MD, Urits I, et al. The ramifications of opioid utilization and outcomes of alternative pain control strategies for total knee arthroplasties. Orthop Rev. 2022. https:\/\/doi.org\/10.52965\/001c.37496.","journal-title":"Orthop Rev"},{"key":"7176_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12891-022-05194-z","volume":"23","author":"M Yuan","year":"2022","unstructured":"Yuan M, Tang T, Ding Z, Li H, Zhou Z. Analgesic effect of perioperative duloxetine in patients after total knee arthroplasty: a prospective, randomized, double-blind, placebo-controlled trial. BMC Musculoskelet Disord. 2022;23:242. https:\/\/doi.org\/10.1186\/s12891-022-05194-z.","journal-title":"BMC Musculoskelet Disord"},{"key":"7176_CR8","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.artd.2023.101097","volume":"20","author":"IA Jones","year":"2023","unstructured":"Jones IA, Talehakimi A, Murphy LS, Wang JC, Piple AS, Christ AB, et al. Duloxetine for postoperative pain control following knee or hip replacement: a systematic review and meta-analysis. Arthroplast Today. 2023;20:101097. https:\/\/doi.org\/10.1016\/j.artd.2023.101097.","journal-title":"Arthroplast Today"},{"key":"7176_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13018-024-04648-5","volume":"19","author":"Y Lin","year":"2024","unstructured":"Lin Y, Jiang M, Liao C, Wu Q, Zhao J. Duloxetine reduces opioid consumption and pain after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2024;19:181. https:\/\/doi.org\/10.1186\/s13018-024-04648-5.","journal-title":"J Orthop Surg Res"},{"key":"7176_CR10","doi-asserted-by":"publisher","DOI":"10.5812\/aapm-127017","author":"F Imani","year":"2023","unstructured":"Imani F, Emami A, Alimian M, Nikoubakht N, Khosravi N, Rajabi M, et al. Comparison of perioperative pregabalin and duloxetine for pain management after total knee arthroplasty: a double-blind clinical trial. Anesthesiol Pain Med. 2023. https:\/\/doi.org\/10.5812\/aapm-127017.","journal-title":"Anesthesiol Pain Med"},{"key":"7176_CR11","doi-asserted-by":"publisher","first-page":"e052944","DOI":"10.1136\/bmjopen-2021-052944","volume":"11","author":"W Rienstra","year":"2021","unstructured":"Rienstra W, Blikman T, Dijkstra B, Stewart R, Zijlstra W, van Raaij T, et al. Effect of preoperative duloxetine treatment on postoperative chronic residual pain after total hip or knee arthroplasty: a randomised controlled trial. BMJ Open. 2021;11:e052944. https:\/\/doi.org\/10.1136\/bmjopen-2021-052944.","journal-title":"BMJ Open"},{"key":"7176_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.arth.2022.10.007","volume":"38","author":"Z Ding","year":"2023","unstructured":"Ding Z, Li H, Huang C, Yuan M, Cao J, Wang H, et al. Significant analgesic benefits of perioperative duloxetine in patients who have depressive symptoms undergoing total hip arthroplasty: a randomized controlled trial. J Arthroplasty. 2023;38:519\u201324. https:\/\/doi.org\/10.1016\/j.arth.2022.10.007.","journal-title":"J Arthroplasty"},{"key":"7176_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2106\/JBJS.18.00347","volume":"101","author":"IJ Koh","year":"2019","unstructured":"Koh IJ, Kim MS, Sohn S, Song KY, Choi NY, In Y. Duloxetine reduces pain and improves quality of recovery following total knee arthroplasty in centrally sensitized patients. J Bone Jt Surg. 2019;101:64\u201373. https:\/\/doi.org\/10.2106\/JBJS.18.00347.","journal-title":"J Bone Jt Surg"},{"key":"7176_CR14","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.3390\/jcm10132809","volume":"10","author":"MS Kim","year":"2021","unstructured":"Kim MS, Koh IJ, Sung YG, Park DC, Na JW, In Y. Preemptive duloxetine relieves postoperative pain and lowers wound temperature in centrally sensitized patients undergoing total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Clin Med. 2021;10:2809. https:\/\/doi.org\/10.3390\/jcm10132809.","journal-title":"J Clin Med"},{"key":"7176_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s12891-021-04377-4","volume":"22","author":"H Li","year":"2021","unstructured":"Li H, Zeng W-N, Ding Z-C, Yuan M-C, Cai Y-R, Zhou Z-K. Duloxetine reduces pain after total hip arthroplasty: a prospective, randomized controlled study. BMC Musculoskelet Disord. 2021;22:492. https:\/\/doi.org\/10.1186\/s12891-021-04377-4.","journal-title":"BMC Musculoskelet Disord"},{"key":"7176_CR16","first-page":"63","volume":"34","author":"AH Inamullah","year":"2023","unstructured":"Inamullah AH, Essa MA, Farooq MZ, Ullah S, Gul Y. Effect of duloxetine on pain relief in patients undergoing arthroplasty. Med Forum Mon. 2023;34:63\u20137.","journal-title":"Med Forum Mon"},{"key":"7176_CR17","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1007\/s00402-024-05591-0","volume":"144","author":"P Pinsornsak","year":"2024","unstructured":"Pinsornsak P, Phunphakchit J, Pinsornsak P, Boontanapibul K. Does postoperative low-dose duloxetine provide analgesic effect and lower morphine consumption after primary total knee arthroplasty? A prospective, double-blind, randomized controlled trial. Arch Orthop Trauma Surg. 2024;144:4979\u201387. https:\/\/doi.org\/10.1007\/s00402-024-05591-0.","journal-title":"Arch Orthop Trauma Surg"},{"key":"7176_CR18","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.arth.2024.02.007","volume":"39","author":"AM Rajani","year":"2024","unstructured":"Rajani AM, Mittal ARS, Kulkarni VU, Desai MK, Dubey RR, Rajani KA. Duloxetine as an analgesic in patients who do not have central sensitivity undergoing single-setting, bilateral total knee arthroplasty: a prospective, double-blinded, randomized, placebo-controlled trial. J Arthroplasty. 2024;39:2055\u201360. https:\/\/doi.org\/10.1016\/j.arth.2024.02.007.","journal-title":"J Arthroplasty"},{"key":"7176_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/bja\/aeq158","volume":"105","author":"K-Y Ho","year":"2010","unstructured":"Ho K-Y, Tay W, Yeo M-C, Liu H, Yeo S-J, Chia S-L, et al. Duloxetine reduces morphine requirements after knee replacement surgery. Br J Anaesth. 2010;105:371\u20136. https:\/\/doi.org\/10.1093\/bja\/aeq158.","journal-title":"Br J Anaesth"},{"key":"7176_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/ALN.0000000000001228","volume":"125","author":"JT YaDeau","year":"2016","unstructured":"YaDeau JT, Brummett CM, Mayman DJ, Lin Y, Goytizolo EA, Padgett DE, et al. Duloxetine and subacute pain after knee arthroplasty when added to a multimodal analgesic regimen. Anesthesiology. 2016;125:561\u201372. https:\/\/doi.org\/10.1097\/ALN.0000000000001228.","journal-title":"Anesthesiology"},{"key":"7176_CR21","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.arth.2022.02.022","volume":"37","author":"JT YaDeau","year":"2022","unstructured":"YaDeau JT, Mayman DJ, Jules-Elysee KM, Lin Y, Padgett DE, DeMeo DA, et al. Effect of duloxetine on opioid use and pain after total knee arthroplasty: a triple-blinded randomized controlled trial. J Arthroplasty. 2022;37:S147\u201354. https:\/\/doi.org\/10.1016\/j.arth.2022.02.022.","journal-title":"J Arthroplasty"},{"key":"7176_CR22","volume-title":"Principles of analgesic use in the treatment of acute pain and cancer pain","author":"C Miaskowski","year":"2008","unstructured":"Miaskowski C, Bair M, Chou R, D\u2019Arcy Y, Hartrick C, Huffman L, et al. Principles of analgesic use in the treatment of acute pain and cancer pain. 6th ed. Glenview, IL: American Pain Society; 2008.","edition":"6th ed"},{"key":"7176_CR23","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/os.70077","volume":"17","author":"N Ramadanov","year":"2025","unstructured":"Ramadanov N, Voss M, Diallo RM, Lettner J, Hakam HT, Prill R, et al. Do meta\u2010analyses of total hip arthroplasty produce reliable results? A systematic review and meta\u2010epidemiological study of statistical methods. Orthop Surg. 2025;17:1936\u201355. https:\/\/doi.org\/10.1111\/os.70077.","journal-title":"Orthop Surg"},{"key":"7176_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1213\/ANE.0000000000007246","volume":"141","author":"J Laigaard","year":"2025","unstructured":"Laigaard J, Karlsen A, Maagaard M, Haxholdt Lunn T, Mathiesen O, Overgaard S. Perioperative analgesic interventions for reduction of persistent postsurgical pain after total hip and knee arthroplasty: a systematic review and meta-analysis. Anesth Analg. 2025;141:765\u201378. https:\/\/doi.org\/10.1213\/ANE.0000000000007246.","journal-title":"Anesth Analg"},{"key":"7176_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43019-025-00297-y","volume":"37","author":"M Boutros","year":"2025","unstructured":"Boutros M, Awad G, Mjahed GA, Mansour E. Simultaneous bilateral total knee arthroplasty lowers reoperation and cost at the expense of higher complications and mortality: a meta-analysis and systematic review. Knee Surg Relat Res. 2025;37:45. https:\/\/doi.org\/10.1186\/s43019-025-00297-y.","journal-title":"Knee Surg Relat Res"},{"key":"7176_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/jpm.2010.9854","volume":"13","author":"MM Kamdar","year":"2010","unstructured":"Kamdar MM. Principles of analgesic use in the treatment of acute pain and cancer pain, sixth edition. J Palliat Med. 2010;13:217\u20138. https:\/\/doi.org\/10.1089\/jpm.2010.9854.","journal-title":"J Palliat Med"},{"key":"7176_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11096-020-01216-9","volume":"43","author":"MW Branton","year":"2021","unstructured":"Branton MW, Hopkins TJ, Nemec EC. Duloxetine for the reduction of opioid use in elective orthopedic surgery: a systematic review and meta-analysis. Int J Clin Pharm. 2021;43:394\u2013403. https:\/\/doi.org\/10.1007\/s11096-020-01216-9.","journal-title":"Int J Clin Pharm"},{"key":"7176_CR28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/pm\/pnad045","volume":"24","author":"A Azimi","year":"2023","unstructured":"Azimi A, Hooshmand E, Mafi AA, Tabatabaei F-S. Effect of duloxetine on opioid consumption and pain after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized clinical trials. Pain Med. 2023;24:1035\u201345. https:\/\/doi.org\/10.1093\/pm\/pnad045.","journal-title":"Pain Med"},{"key":"7176_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11096-023-01593-x","volume":"46","author":"H Zhong","year":"2024","unstructured":"Zhong H, Li J, Chen Y, Huang Y, Wen Z, Zhao J. Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Int J Clin Pharm. 2024;46:14\u201325. https:\/\/doi.org\/10.1007\/s11096-023-01593-x.","journal-title":"Int J Clin Pharm"},{"key":"7176_CR30","doi-asserted-by":"publisher","first-page":"e34895","DOI":"10.1097\/MD.0000000000034895","volume":"102","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Chen X, Chen C, Cao Y. The efficacy and safety of duloxetine for the treatment of patients after TKA or THA: a systematic review and meta-analysis. Medicine. 2023;102:e34895. https:\/\/doi.org\/10.1097\/MD.0000000000034895.","journal-title":"Medicine"},{"key":"7176_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/JS9.0000000000000230","volume":"109","author":"J-M Yang","year":"2023","unstructured":"Yang J-M, Wang Y, Li J-Y, Li C-C, Wang Z-T, Shen Z, et al. Duloxetine for rehabilitation after total knee arthroplasty: a systematic review and meta-analysis. Int J Surg. 2023;109:913\u201324. https:\/\/doi.org\/10.1097\/JS9.0000000000000230.","journal-title":"Int J Surg"},{"key":"7176_CR32","doi-asserted-by":"publisher","first-page":"e33101","DOI":"10.1097\/MD.0000000000033101","volume":"102","author":"L-K Zhang","year":"2023","unstructured":"Zhang L-K, Li Q, Fang Y-F, Qi J-W. Effect of duloxetine on pain relief after total knee arthroplasty: a meta-analysis of randomized controlled trials. Medicine. 2023;102:e33101. https:\/\/doi.org\/10.1097\/MD.0000000000033101.","journal-title":"Medicine"},{"key":"7176_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00590-025-04492-1","volume":"35","author":"M Boutros","year":"2025","unstructured":"Boutros M, Awad G, Abboud E, Zhao A, Thakkar SC. Total knee arthroplasty with or without a tourniquet: a meta-analysis of randomized controlled trials. Eur J Orthop Surg Traumatol. 2025;35:397. https:\/\/doi.org\/10.1007\/s00590-025-04492-1.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"7176_CR34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.101791","author":"MS Alasbali","year":"2026","unstructured":"Alasbali MS, Alshammari YA, Alhomaidi MS, Alaqil IA, Sharif MA, Al-Shahir AM, et al. Preoperative central sensitization as a predictor of pain outcomes after hip and knee arthroplasty: a systematic review. Cureus. 2026. https:\/\/doi.org\/10.7759\/cureus.101791.","journal-title":"Cureus"},{"key":"7176_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s12630-021-02145-5","volume":"69","author":"B Chan","year":"2022","unstructured":"Chan B, Ward S, Abdallah FW, Jones C, Papachristos A, Chin K, et al. Opioid prescribing and utilization patterns in patients having elective hip and knee arthroplasty: association between prescription patterns and opioid consumption. Can J Anaesth. 2022;69:953\u201362. https:\/\/doi.org\/10.1007\/s12630-021-02145-5.","journal-title":"Can J Anaesth"},{"key":"7176_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/a-2741-1246","volume":"39","author":"M Boutros","year":"2026","unstructured":"Boutros M, Awad G, Mouawad A, Mansour E. Kinematic versus mechanically aligned total knee arthroplasty: a meta-analysis of randomized controlled trials. J Knee Surg. 2026;39:283\u201395. https:\/\/doi.org\/10.1055\/a-2741-1246.","journal-title":"J Knee Surg"},{"key":"7176_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s43019-026-00316-6","volume":"38","author":"M Boutros","year":"2026","unstructured":"Boutros M, Awad G, Hassan C, Hammad S, Assi J, Haykal G, et al. Cross-cultural adaptation and psychometric validation of the first Arabic KOOS-12: a reliable tool for assessing knee outcomes in Arabic-speaking populations. Knee Surg Relat Res. 2026;38:16. https:\/\/doi.org\/10.1186\/s43019-026-00316-6.","journal-title":"Knee Surg Relat Res"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-026-07176-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-07176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-07176-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:04:12Z","timestamp":1788332652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13018-026-07176-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7176"],"URL":"https:\/\/doi.org\/10.1186\/s13018-026-07176-6","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"527"}}